摘要
^(131)I治疗格雷夫斯病(GD)的疗效和安全性等已得到国内外学者认可,但对具体治疗剂量的选择仍然存在一定争议。治疗目标不同,剂量选择方案也不同。国内学者多选择计算剂量法与个体化相结合的方案,国外学者多选择固定剂量方案。笔者就国内外 ^(131)I治疗GD的剂量确定方法作一综述。
The curative efficacy and safety of the ^(131)I therapy of Graves'disease have been recognized by most domestic and international scholars,but the choice of the specific therapeutic dose is still controversial.According to different therapeutic targets,the choice of the dose-determination scheme is also different.Domestic scholars mostly choose the combination of calculated dose method individualized scheme,while foreign scholars mostly choose the fixed dose scheme.This article reviews the dose-determination schemes of ^(131)I therapy for Graves'disease.
作者
张晗玉
段炼
Zhang Hanyu;Duan Lian(Major of Imaging Medicine and Nuclear Medicine,Graduate School of Changzhi Medical College,Changzhi 046000,China;Department of Nuclear Medicine,Heping Hospital Affiliated to Changzhi Medical College,Changzhi 046000,China)
出处
《国际放射医学核医学杂志》
2021年第11期721-727,共7页
International Journal of Radiation Medicine and Nuclear Medicine